CSIMarket
 


Haemonetics Corporation  (HAE)
Other Ticker:  
 

Haemonetics's Quick Ratio

HAE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 0.74 below Haemonetics's average Quick Ratio.

Within Medical Equipment & Supplies industry 5 other companies have achieved higher Quick Ratio than Haemonetics in third quarter 2023. While Quick Ratio total ranking has improved so far during the III Quarter 2023 to 175, from total ranking in the second quarter 2023 at 1426.

Explain Quick Ratio?
How much Cash & cash equivalents HAE´s has?
What are HAE´s Current Liabilities?


HAE Quick Ratio (Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities Change 15.37 % 0.78 % 31.28 % -43.06 % -36.16 %
Y / Y Cash & cash equivalent Change -13.4 % 45.52 % 32.92 % 9.62 % -5.44 %
Quick Ratio MRQ 0.74 1.33 1.21 1.13 0.99
HAE's Total Ranking # 175 # 1426 # 1068 # 1606 # 103
Seq. Current Liabilities Change -0.93 % 11.51 % -5.91 % 10.99 % -13.46 %
Seq. Cash & cash equivalent Change -44.74 % 22.85 % 0.44 % 26.99 % -7.13 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 23
Overall Market # 175


Quick Ratio Statistics
High Average Low
1.94 0.87 0.47
(Jun 30 2012)   (Sep 28 2019)




Financial Statements
Haemonetics's Current Liabilities $ 262 Millions Visit HAE's Balance sheet
Haemonetics's Cash & cash equivalent $ 194 Millions Visit HAE's Balance sheet
Source of HAE's Sales Visit HAE's Sales by Geography


Cumulative Haemonetics's Quick Ratio

HAE's Quick Ratio for the trailling 12 Months

HAE Quick Ratio

(Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 15.37 % 0.78 % 31.28 % -43.06 % -36.16 %
Y / Y Cash & cash equivalent TTM Growth -13.4 % 45.52 % 32.92 % 9.62 % -5.44 %
Quick Ratio TTM 1.1 1.17 1.06 1.05 0.85
Total Ranking TTM # 735 # 1278 # 1483 # 1641 # 2159
Seq. Current Liabilities TTM Growth -0.93 % 11.51 % -5.91 % 10.99 % -13.46 %
Seq. Cash & cash equivalent TTM Growth -44.74 % 22.85 % 0.44 % 26.99 % -7.13 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the III Quarter 2023 to $261.76 millions, cumulative Quick Ratio decreased to 1.1 above the HAE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 123 other companies have achieved higher Quick Ratio than Haemonetics. While Quick Ratio overall ranking has improved so far to 590, from total ranking during the twelve months ending second quarter 2023 at 3659.

Explain Quick Ratio?
How much Cash & cash equivalents HAE´s has?
What are HAE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 124
Healthcare Sector # 482
Within the Market # 175


trailing twelve months Quick Ratio Statistics
High Average Low
1.17 0.76 0.53
(Sep 30 2023)   (Mar 28 2020)




Companies with similar Quick Ratio in the quarter ending Dec 30 2023, within Medical Equipment & Supplies Industry Quick RatioDec 30 2023 MRQ Cash & cash equivalentDec 30 2023 MRQ Current Liabilities
Delcath Systems Inc   1.98 $ 32.504  Millions$ 16.448  Millions
Neuroone Medical Technologies Corporation  1.94 $ 2.681  Millions$ 1.383  Millions
Penumbra Inc   1.91 $ 289.187  Millions$ 151.144  Millions
Modular Medical Inc   1.90 $ 2.047  Millions$ 1.077  Millions
Atricure Inc   1.84 $ 137.285  Millions$ 74.569  Millions
Mimedx Group Inc   1.78 $ 82.000  Millions$ 46.008  Millions
Livanova Plc  1.73 $ 577.872  Millions$ 334.983  Millions
Warby Parker Inc   1.71 $ 216.894  Millions$ 127.090  Millions
Tactile Systems Technology Inc   1.60 $ 61.033  Millions$ 38.250  Millions
Electromed Inc   1.59 $ 10.434  Millions$ 6.573  Millions
Inari Medical Inc   1.51 $ 115.452  Millions$ 76.339  Millions
Si bone inc   1.51 $ 33.271  Millions$ 22.040  Millions
Irhythm Technologies Inc   1.50 $ 133.764  Millions$ 88.905  Millions
Stereotaxis Inc   1.50 $ 19.818  Millions$ 13.247  Millions
Edwards Lifesciences Corporation  1.38 $ 1,644.500  Millions$ 1,195.400  Millions
Electrocore Inc   1.29 $ 10.331  Millions$ 8.034  Millions
West Pharmaceutical Services Inc   1.27 $ 853.900  Millions$ 671.800  Millions
Autonomix Medical Inc   1.25 $ 1.218  Millions$ 0.973  Millions
Biolife Solutions Inc   1.23 $ 51.695  Millions$ 42.178  Millions
Envista Holdings Corporation  1.20 $ 940.000  Millions$ 780.800  Millions
Nuwellis Inc   1.20 $ 3.800  Millions$ 3.172  Millions
Integra Lifesciences Holdings Corp  1.09 $ 309.096  Millions$ 283.156  Millions
Artivion Inc   1.02 $ 58.940  Millions$ 57.862  Millions
Privia Health Group Inc   1.01 $ 389.511  Millions$ 383.909  Millions
Cytosorbents Corporation  0.97 $ 14.131  Millions$ 14.546  Millions
Cadre Holdings Inc   0.92 $ 87.691  Millions$ 95.206  Millions
Embecta Corp   0.91 $ 298.700  Millions$ 326.600  Millions
Medtronic Plc  0.85 $ 8,321.000  Millions$ 9,793.000  Millions
Innovage Holding Corp   0.80 $ 98.771  Millions$ 123.132  Millions
Angiodynamics Inc   0.78 $ 60.896  Millions$ 78.037  Millions

Date modified: 2024-02-08T15:54:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com